{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:04:11Z","timestamp":1792011851597,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on characteristics and clinical course of long-term survivors with CRC-PM beyond 5\u2009years. The objective of this study was to identify the clinical and oncological features affecting long-term survival of CRC-PM after comprehensive treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between January 1990 and April 2015, CRC-PM patients who underwent CRS with or without HIPEC in two Japanese tertiary hospitals were analyzed. Clinicopathological parameters and therapeutic details for long-term survivors (patients surviving \u2265 5\u2009years after CRS) were described and compared with those for non-survivors (patients surviving &lt;\u20095\u2009years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study identified 236 patients with CRC-PM who underwent CRS, with a median follow-up period of 2.5\u2009years. Thirty-three patients (14.0%) were considered as long-term survivors. Compared with non-survivors, long-term survivors had a lower median peritoneal cancer index (PCI) [4 (1\u201327) vs 9 (0\u201339),\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.001]. Complete cytoreduction (CCR-0) was achieved in all long-term survivors, with a significantly higher rate [33\/33 (100%) vs 141\/203 (69.8%),\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.001]. Metachronous onsets of PM were more frequently observed in the long-term survivor group [26\/33 (78.8%) vs 103\/203 (50.3%),\n                      <jats:italic>p<\/jats:italic>\n                      = 0.018]. Regarding histopathology, long-term survivors more frequently had mucinous adenocarcinoma than non-survivors [8\/33 (24.2%) vs 27\/203 (13.3%)] and less likely exhibited poorly differentiated or signet ring cell carcinoma [2\/33 (6.1%) vs 48\/203 (23.7%)] (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>One in seven patients with CRC-PM achieved the long-term milestone after CRS. A long-term survival was associated with the presence of low PCI, CCR-0, metachronous onset, and mucinous histology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-021-02145-1","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T10:04:00Z","timestamp":1611828240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-1203","authenticated-orcid":false,"given":"Yasuyuki","family":"Kamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koya","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruaki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouzou","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"2145_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2145_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545\u201350.","journal-title":"Br J Surg"},{"key":"2145_CR3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/ijc.25596","volume":"128","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717\u201325.","journal-title":"Int J Cancer"},{"key":"2145_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699\u2013705.","journal-title":"Br J Surg"},{"key":"2145_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","volume":"38","author":"YRBM van Gestel","year":"2014","unstructured":"van Gestel YRBM, de Hingh IHJT, van Herk-Sukel MPP, van Erning FN, Beerepoot LV, Wijsman JH, et al. Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol. 2014;38:448\u201354.","journal-title":"Cancer Epidemiol"},{"key":"2145_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","volume":"63","author":"DZ Chu","year":"1989","unstructured":"Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63:364\u20137.","journal-title":"Cancer"},{"key":"2145_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358\u201363.","journal-title":"Cancer"},{"key":"2145_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","volume":"38","author":"YLB Klaver","year":"2012","unstructured":"Klaver YLB, Simkens LHJ, Lemmens VEPP, Koopman M, Teerenstra S, Bleichrodt RP, et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38:617\u201323.","journal-title":"Eur J Surg Oncol"},{"key":"2145_CR9","doi-asserted-by":"publisher","first-page":"18632","DOI":"10.1038\/srep18632","volume":"5","author":"TR van Oudheusden","year":"2015","unstructured":"van Oudheusden TR, Razenberg LG, van Gestel YR, Creemers GJ, Lemmens VE, de Hingh IH. Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin. Sci Rep. 2015;5:18632.","journal-title":"Sci Rep"},{"key":"2145_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol"},{"key":"2145_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00432-013-1517-y","volume":"139","author":"L Ung","year":"2013","unstructured":"Ung L, Chua TC, David LM. Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy. J Cancer Res Clin Oncol. 2013;139:1899\u2013908.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2145_CR12","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426\u201332.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR13","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392.","journal-title":"J Clin Oncol"},{"key":"2145_CR14","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116:5608\u201318.","journal-title":"Cancer"},{"key":"2145_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejso.2012.03.001","volume":"38","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol. 2012;38:509\u201315.","journal-title":"Eur J Surg Oncol"},{"key":"2145_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe J-M, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135.","journal-title":"J Clin Oncol"},{"key":"2145_CR17","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1002\/cncr.25116","volume":"116","author":"J Franko","year":"2010","unstructured":"Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer. 2010;116:3756\u201362.","journal-title":"Cancer"},{"key":"2145_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1245\/s10434-012-2264-z","volume":"19","author":"D Hompes","year":"2012","unstructured":"Hompes D, D\u2019Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Ann Surg Oncol. 2012;19:2186\u201394.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR19","first-page":"747","volume":"20","author":"F Cavaliere","year":"2006","unstructured":"Cavaliere F, Valle M, De Simone M, Deraco M, Rossi CR, Di Filippo F, et al. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study. Vivo Athens Greece. 2006;20:747\u201350.","journal-title":"Vivo Athens Greece"},{"key":"2145_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis. 2015;17:772\u20138.","journal-title":"Colorectal Dis"},{"key":"2145_CR21","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol"},{"key":"2145_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3:585\u201394.","journal-title":"BJS Open"},{"key":"2145_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/SLA.0000000000001593","volume":"263","author":"R Kwakman","year":"2016","unstructured":"Kwakman R, Schrama AM, van Olmen JP, Otten RH, de Lange-de Klerk ES, de Cuba EM, et al. Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis. Ann Surg. 2016;263:1102\u201311.","journal-title":"Ann Surg"},{"key":"2145_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","volume":"37","author":"F Cavaliere","year":"2011","unstructured":"Cavaliere F, De Simone M, Virz\u00ec S, Deraco M, Rossi CR, Garofalo A, et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2011;37:148\u201354.","journal-title":"Eur J Surg Oncol"},{"key":"2145_CR25","doi-asserted-by":"publisher","first-page":"978394","DOI":"10.1155\/2013\/978394","volume":"2013","author":"Y Yonemura","year":"2013","unstructured":"Yonemura Y, Canbay E, Ishibashi H. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. Sci World J. 2013;2013:978394.","journal-title":"Sci World J"},{"key":"2145_CR26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier A-S, Blot F, Go\u00e9r\u00e9 D, Dumont F, et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol. 2014;40:1467\u201373.","journal-title":"Eur J Surg Oncol"},{"key":"2145_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg"},{"key":"2145_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"key":"2145_CR29","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","volume":"21","author":"K Turaga","year":"2014","unstructured":"Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, et al. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21:1501\u20135.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"2145_CR31","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1245\/s10434-018-6436-3","volume":"25","author":"D Shida","year":"2018","unstructured":"Shida D, Yoshida T, Tanabe T, Tsukamoto S, Ochiai H, Kanemitsu Y. Prognostic impact of R0 resection and targeted therapy for colorectal cancer with synchronous peritoneal metastasis. Ann Surg Oncol. 2018;25:1646\u201353.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1245\/s10434-018-6992-6","volume":"26","author":"P Piso","year":"2019","unstructured":"Piso P, Nedelcut SD, Rau B, K\u00f6nigsrainer A, Glockzin G, Str\u00f6hlein MA, et al. Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ registry with 2149 consecutive patients. Ann Surg Oncol. 2019;26:148\u201354.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR33","first-page":"99","volume":"7","author":"AD Newton","year":"2016","unstructured":"Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016;7:99\u2013111.","journal-title":"J Gastrointest Oncol"},{"key":"2145_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution\u2019s experience during two decades. Ann Surg Oncol. 2017;24:898\u2013905.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11912-018-0703-0","volume":"20","author":"PH Sugarbaker","year":"2018","unstructured":"Sugarbaker PH. Peritoneal metastases from gastrointestinal cancer. Curr Oncol Rep. 2018;20:62.","journal-title":"Curr Oncol Rep"},{"key":"2145_CR36","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1245\/s10434-013-3328-4","volume":"21","author":"J Winer","year":"2014","unstructured":"Winer J, Zenati M, Ramalingam L, Jones H, Zureikat A, Holtzman M, et al. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2014;21:1456\u201362.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder J-M, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol"},{"key":"2145_CR38","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SLA.0b013e31818a15b5","volume":"248","author":"TD Yan","year":"2008","unstructured":"Yan TD, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg. 2008;248:829\u201335.","journal-title":"Ann Surg"},{"key":"2145_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/jso.23446","volume":"109","author":"JD Rivard","year":"2014","unstructured":"Rivard JD, McConnell YJ, Temple WJ, Mack LA. Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit? J Surg Oncol. 2014;109:104\u20139.","journal-title":"J Surg Oncol"},{"key":"2145_CR40","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M, Cloutier AS, Viana B, Honor\u00e9 C, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22:2958\u201364.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","volume":"23","author":"M Faron","year":"2016","unstructured":"Faron M, Macovei R, Go\u00e9r\u00e9 D, Honor\u00e9 C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23:114\u20139.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/jso.25044","volume":"117","author":"F Bagante","year":"2018","unstructured":"Bagante F, Spolverato G, Beal E, Merath K, Chen Q, Akg\u00fcl O, et al. Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer. J Surg Oncol. 2018;117:1355\u201363.","journal-title":"J Surg Oncol"},{"key":"2145_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF02050301","volume":"36","author":"JB Green","year":"1993","unstructured":"Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB, Ray JE. Mucinous carcinoma--just another colon cancer? Dis Colon Rectum. 1993;36:49\u201354.","journal-title":"Dis Colon Rectum"},{"key":"2145_CR44","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1365-2559.2011.04155.x","volume":"60","author":"C Langner","year":"2012","unstructured":"Langner C, Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, et al. Mucinous differentiation in colorectal cancer--indicator of poor prognosis? Histopathology. 2012;60:1060\u201372.","journal-title":"Histopathology"},{"key":"2145_CR45","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1700::AID-CNCR11>3.0.CO;2-4","volume":"86","author":"QT Le","year":"1999","unstructured":"Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Cancer. 1999;86:1700\u201311.","journal-title":"Cancer"},{"key":"2145_CR46","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1245\/s10434-009-0536-z","volume":"16","author":"TC Chua","year":"2009","unstructured":"Chua TC, Pelz JOW, Kerscher A, Morris DL, Esquivel J. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma. Ann Surg Oncol. 2009;16:2765\u201370.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/bjs.4516","volume":"91","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2004;91:739\u201346.","journal-title":"Br J Surg"},{"key":"2145_CR48","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/1471-2407-10-689","volume":"10","author":"JOW Pelz","year":"2010","unstructured":"Pelz JOW, Chua TC, Esquivel J, Stojadinovic A, Doerfer J, Morris DL, et al. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010;10:689.","journal-title":"BMC Cancer"},{"key":"2145_CR49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.surg.2012.07.027","volume":"152","author":"HL Van Sweringen","year":"2012","unstructured":"Van Sweringen HL, Hanseman DJ, Ahmad SA, Edwards MJ, Sussman JJ. Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surgery. 2012;152:617\u201324 discussion 624-625.","journal-title":"Surgery"},{"key":"2145_CR50","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1245\/s10434-019-07294-y","volume":"26","author":"JEKR Hentzen","year":"2019","unstructured":"Hentzen JEKR, Rovers KP, Kuipers H, van der Plas WY, Been LB, Hoogwater FJH, et al. Impact of synchronous versus metachronous onset of colorectal peritoneal metastases on survival outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a multicenter, retrospective, observational study. Ann Surg Oncol. 2019;26:2210\u201321.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR51","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/jso.23597","volume":"109","author":"HJ Braam","year":"2014","unstructured":"Braam HJ, van Oudheusden TR, de Hingh IHJT, Nienhuijs SW, Boerma D, Wiezer MJ, et al. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. J Surg Oncol. 2014;109:841\u20137.","journal-title":"J Surg Oncol"},{"key":"2145_CR52","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s00268-009-0059-6","volume":"33","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Ng KM, Zhao J, Morris DL. Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis. World J Surg. 2009;33:1488\u201394.","journal-title":"World J Surg"},{"key":"2145_CR53","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","volume":"22","author":"JM Baumgartner","year":"2015","unstructured":"Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22:1716\u201321.","journal-title":"Ann Surg Oncol"},{"key":"2145_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/CMAR.S119569","volume":"9","author":"GA Simkens","year":"2017","unstructured":"Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res. 2017;9:259\u201366.","journal-title":"Cancer Manag Res"},{"key":"2145_CR55","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bjs.1800691019","volume":"69","author":"RJ Heald","year":"1982","unstructured":"Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg. 1982;69:613\u20136.","journal-title":"Br J Surg"},{"key":"2145_CR56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1463-1318.2008.01735.x","volume":"11","author":"W Hohenberger","year":"2009","unstructured":"Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009;11:354\u201364 discussion 364-365.","journal-title":"Colorectal Dis"},{"key":"2145_CR57","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","volume":"36","author":"F Quenet","year":"2018","unstructured":"Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36:3503.","journal-title":"J Clin Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-021-02145-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T15:54:56Z","timestamp":1619106896000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02145-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2145"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02145-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-104732\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"4 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study of was approved by the institutional review boards and was also conducted in accordance with the Declaration of Helsinki, and all patients signed the informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}